Last updated on December 2015

A Double-Blind, Randomized, Placebo Controlled Study of CM_AT for the Treatment of Autism in Children 3-8 Years Old. (The Blüm Study)


Brief description of study

A Double-Blind, Randomized, Placebo Controlled Study of CM_AT for the Treatment of Autism in Children 3-8 Years Old. (The Blüm Study)

Detailed Study Description

Autism is clearly a significant cause of disability in the pediatric population. Many children with Autism exhibit impaired protein digestion which may or may not manifest in self-restricted diets. The inability to digest protein affects the availability of essential amino acids in the body. CM-AT is designed to enhance protein digestion thereby potentially restoring the pool of essential amino acids. Essential amino acids play a critical role in the expression of several genes important to neurological function and serve as precursors to key neurotransmitters such as serotonin and dopamine.

CM-AT is a proprietary enzyme that is designed as a granulated powder to be taken three times daily.

Watch this video to learn more about the Blüm Study, the clinical trial of CM-AT, an investigational new drug, for the treatment of Autism in children 3-8 years of age.

The Blüm Study

Clinical Study Identifier: TX142059

Contact Investigators or Research Sites near you

Start Over

Jennifer Andrews

University of Arizona Medical Center
Tucson, AZ USA
  Connect »

Sharman Ober-Reynolds

Southwest Autism Research & Resource Center (S.A.R.R.C.)
Phoenix, AZ USA
  Connect »

Rosleen Mansour

The University of Texas, Houston - Department of Psychiatry and Behavioral Sciences
Houston, TX USA
  Connect »

Jany Paulett

University of Toledo
Toledo, OH USA
  Connect »

Laura Potter

UC Davis MIND Institute
Sacramento, CA USA
  Connect »

Emily Zetzer

Cleveland Clinic Center for Autism Research
Cleveland, OH USA
  Connect »

Gretchen Ashruf

The Duke Center for Autism & Brain Development
Durham, NC USA
  Connect »

Jessica Mudge

Detroit Clinical Research Center
Bingham Farms, MI USA
  Connect »

Kaley Killdahl

APG Research, LLC
Orlando, FL USA
  Connect »

Heidi Andersen

Lake Mary Pediatrics
Orange City, FL USA
  Connect »

Pooja Palkar

Montefiore Medical Center - Autism and Obsessive Compulsive Spectrum Program
Bronx, NY USA
  Connect »

Stephanie Saunders

LSU Health Sciences Center
Shreveport, LA USA
  Connect »

Kristen Holmes

Lovelace Scientific Resources
Albuquerque, NM USA
  Connect »

Patty Feole, RN

Omega Medical Research
Warwick, RI USA
  Connect »

Felicia Widjaja

UCSF
San Francisco, CA USA
  Connect »

Rochelle Brown

Carilion Clinic
Roanoke, VA USA
  Connect »

EmmaLee Schreck

Ericksen Research & Development
Clinton, UT USA
  Connect »

Sarah Marler

Vanderbilt University Medical Center
Nashville, TN USA
  Connect »

Daniella Van Blitter

NRC Reseach Institute
Orange, CA USA
  Connect »

John Slattery

Arkansas Children's Hospital Research Institute
Little Rock, AR USA
  Connect »

Roger Jou

Yale Child Study Center
New Haven, CT USA
  Connect »

AnnaRita Colacino

Richmond Behavioral Associates
Staten Island, NY USA
  Connect »

Kenneth Dole

IMMUNOe Research Centers
Centennial, CO USA
  Connect »

Catherine Smith

Clinical Research Center of NJ (CRCNJ)
Voorhees, NJ USA
  Connect »

Ashley Dayson

Segal Institute for Clinical Research
Charleston, SC USA
  Connect »

Melissa Andrews

NeuroScience, Inc
Herndon, VA USA
  Connect »

Melanie Niederhauser

Children’s Specialized Hospital
Toms River, NJ USA
  Connect »

Amanda Johnson

Research Institute of Deaconess Clinic
Newburgh, IN USA
  Connect »

Monica Periasamy

University of Virginia Center for Psychopharmacology Research in Youth
Charlottesville, VA USA
  Connect »

Melanie Niederhauser

Children’s Specialized Hospital
Egg Harbor Township, NJ USA
  Connect »

Kenneth Dole

IMMUNOe Research Centers
Thornton, CO USA
  Connect »